Literature DB >> 2430586

Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever.

E Hacbarth, A Kajdacsy-Balla.   

Abstract

Ficoll-Hypaque density gradient preparations of peripheral blood mononuclear cells from patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever were highly "contaminated" with low buoyant density neutrophils. Plasma from these patients could induce an in vitro decrease of buoyancy in neutrophils with normal buoyant density. Similar change could be induced by complement-activated sera and aggregated gamma globulin. These data suggest that activated neutrophils are a common finding in the peripheral blood of these patients and may influence the interpretation of any studies with these cells. Functional studies of lymphocytes separated by Ficoll-Hypaque gradients should also take into account the higher degree of impurity of the cell preparations in patients with rheumatic diseases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430586     DOI: 10.1002/art.1780291105

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  97 in total

Review 1.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

2.  Primed PMNs in healthy mouse and human circulation are first responders during acute inflammation.

Authors:  Noah Fine; Oriyah Barzilay; Chunxiang Sun; Nimali Wellappuli; Farzeen Tanwir; Jeffrey W Chadwick; Morvarid Oveisi; Nikola Tasevski; David Prescott; Martin Gargan; Dana J Philpott; Yigal Dror; Michael Glogauer
Journal:  Blood Adv       Date:  2019-05-28

3.  A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease.

Authors:  Jingran Zhou; Ruiqiong Wu; Anthony A High; Clive A Slaughter; David Finkelstein; Jerold E Rehg; Vanessa Redecke; Hans Häcker
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

Review 4.  Interferon Lambda's New Role as Regulator of Neutrophil Function.

Authors:  Amariliz Rivera
Journal:  J Interferon Cytokine Res       Date:  2019-04-23       Impact factor: 2.607

5.  Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome.

Authors:  Pragnesh Mistry; Carmelo Carmona-Rivera; Amanda K Ombrello; Patrycja Hoffmann; Nickie L Seto; Anne Jones; Deborah L Stone; Faiza Naz; Philip Carlucci; Stefania Dell'Orso; Gustavo Gutierrez-Cruz; Hong-Wei Sun; Daniel L Kastner; Ivona Aksentijevich; Mariana J Kaplan
Journal:  Ann Rheum Dis       Date:  2018-08-21       Impact factor: 19.103

Review 6.  The role of neutrophils and NETosis in autoimmune and renal diseases.

Authors:  Sarthak Gupta; Mariana J Kaplan
Journal:  Nat Rev Nephrol       Date:  2016-05-31       Impact factor: 28.314

7.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

8.  Polymorphonuclear leukocyte chemiluminescence response in HLA-B27 positive and negative arthritic patients.

Authors:  R Tertti
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

9.  Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

Authors:  J S Savill; A H Wyllie; J E Henson; M J Walport; P M Henson; C Haslett
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

10.  A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.

Authors:  T Kurz; M Weiner; C Skoglund; S Basnet; P Eriksson; M Segelmark
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.